“MxA Gene Expression Analysis as an Interferon-beta Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity”
- Law and Technology
- Health Law
Molecular Diagnosis
2003